RxDoctor Payments Data

Derek Dillon, DO

Family Medicine · Dunedin, FLNPI 1023491222

Payments from drug & device makers

$1,265in general payments, 2019–2025

Across 78 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$305
  • AbbVie$264
  • Pfizer$194
  • Novo Nordisk$98
  • GSK$89
  • Lilly USA, LLC$76
  • plus $239 from 9 others

What the payments were for

  • Food & beverage$1,265100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,265 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$93,077
Medicare patients
330
Services billed
1,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$78,935
EliquisApixaban63$59,869
XareltoRivaroxaban43$42,788
JardianceEmpagliflozin32$41,482
FarxigaDapagliflozin Propanediol36$25,497
MounjaroTirzepatide21$20,210
TrulicityDulaglutide15$16,041
EntrestoSacubitril/Valsartan18$14,508
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$12,283
Repatha SureclickEvolocumab11$7,522
Incruse ElliptaUmeclidinium Bromide17$7,105
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$5,052
Atorvastatin Calcium438$4,278
SymbicortBudesonide/Formoterol Fumarate13$3,718
Levothyroxine Sodium323$3,229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$98$81,51295 claims
PfizerEliquis$194$59,86963 claims
Johnson & JohnsonXarelto$45$42,78843 claims
Lilly USA, LLCMounjaro, Trulicity$76$36,25136 claims
AstraZenecaFarxiga, Symbicort$305$29,21549 claims
GSKAnoro Ellipta, Incruse Ellipta$89$19,38935 claims
NovartisEntresto$70$14,50818 claims
AbbVieSynthroid$264$85817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Dunedin

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →